CorMedix Inc.
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(a) On August 6, 2025, the Company filed a Third Amended and Restated Certificate of Designation of the Series E Convertible Preferred Stock (the “Series E Preferred Stock”) with the Secretary of State of the State of Delaware modifying certain of the covenants and other terms thereof including the stated value per share of Series E Preferred Stock. The Third Amended and Restated Certificate of Designation was effective upon acceptance by the Secretary of State of the State of Delaware.
(c) None of our officers or directors, as defined in Rule 16a-1(f), adopted, modified, orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K, during the six months ended June 30, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.